Cleveland BioLabs, Inc.
(NASDAQ CM: CBLI)
Rigrodsky Law, P.A. is investigating Cleveland BioLabs, Inc. (“Cleveland”) regarding possible breaches of fiduciary duties and other violations of law related to Cleveland’s agreement to merge with Cytocom, Inc. ("Cytocom"). Under the terms of the agreement, Cleveland will issue a number of shares of Cleveland common stock to shareholders of Cytocom.